Linking early and late endpoints in adjuvant immunotherapy trials: an evaluation of multiple clinical outcomes

Sirui Tang, Huiran Zang, Linhan Mao, Xingyu Liu, Xinyu Li

Open source

DOI
10.1093/oncolo/oyag342
Published
2026-08-22
Container
The Oncologist
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyag342,
  title = {Linking early and late endpoints in adjuvant immunotherapy trials: an evaluation of multiple clinical outcomes},
  author = {Sirui Tang and Huiran Zang and Linhan Mao and Xingyu Liu and Xinyu Li},
  year = {2026},
  journal = {The Oncologist},
  doi = {10.1093/oncolo/oyag342},
  url = {https://doi.org/10.1093/oncolo/oyag342}
}

RIS

TY  - JOUR
TI  - Linking early and late endpoints in adjuvant immunotherapy trials: an evaluation of multiple clinical outcomes
AU  - Sirui Tang
AU  - Huiran Zang
AU  - Linhan Mao
AU  - Xingyu Liu
AU  - Xinyu Li
PY  - 2026
JO  - The Oncologist
DO  - 10.1093/oncolo/oyag342
UR  - https://doi.org/10.1093/oncolo/oyag342
ER  - 

APA

Tang, S., Zang, H., Mao, L., Liu, X., & Li, X. (2026). Linking early and late endpoints in adjuvant immunotherapy trials: an evaluation of multiple clinical outcomes. The Oncologist. https://doi.org/10.1093/oncolo/oyag342

Source records